The trademark application AVANTEC was filed by Avantec Vascular Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on September 28, 2023, and it was registered by office on January 5, 2024 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Cardiovascular pharmaceutical preparations
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Drug delivery agents in the form of a coating for an implantable device that facilitate the delivery of a wide range of pharmaceuticals
Drug delivery agents in the form of a coating for an implantable vascular device that facilitate the delivery of a wide range of pharmaceuticals
Drug delivery agents in the form of a coating for a stent that facilitate the delivery of a wide range of pharmaceuticals
Drug delivery agents in the form of a coating for a vascular stent that facilitate the delivery of a wide range of pharmaceuticals
Drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical preparations
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Pharmaceutical preparations for the treatment and prevention of vascular disease
Pharmaceutical preparations for the treatment and prevention of restenosis
Pharmaceutical preparations for the treatment and prevention of inflammation.
The mark was filed in class 10 with following description of goods:
Medical devices for use in treating vascular disease
Medical devices for use in treating a thrombosis
Medical devices for use in treating cardiovascular disease
Medical devices for use in treating atherosclerosis